Biotech · Private company
Vectura Limited
Track this companyFree. Adds Vectura Limited to your Dealase workspace and tells you when its record changes.
Clinical trials70 recruiting or active
Pipeline programs13From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline13
- VR506Phase 3 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- 0.5 mg/2 mL Pulmicort Respules delivered by a conventional jet nebulizer (PARI VIOS) with mouthpiecePhase 1 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- 1 mg/2 mL Pulmicort Respules delivered by a conventional jet nebulizerPhase 1 · WheezingClinicalTrials.gov · fetched Nov 12, 2026
- 1 mg/2 mL Pulmicort Respules delivered by a conventional jet nebulizer (PARI VIOS) with mouthpiecePhase 1 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- ASAPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- non-enteric-coated chewable aspirinPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- single dose (100 mg) of ASAPhase 1 · Obstructive Pulmonary FunctionClinicalTrials.gov · fetched Nov 12, 2026
- single dose (162 mg) of non-enteric-coated chewable aspirin tabletsPhase 1 · Obstructive Pulmonary FunctionClinicalTrials.gov · fetched Nov 12, 2026
- VR647 Inhalation Suspension (budesonide) 1 mg/2 mL delivered by the VR647 Inhalation SystemPhase 1 · WheezingClinicalTrials.gov · fetched Nov 12, 2026
- VR647 Inhalation Suspension (budesonide) 1 mg/2 mL delivered by the VR647 Inhalation System (AKITA JET) with mouthpiecePhase 1 · AsthmaClinicalTrials.gov · fetched Nov 12, 2026
- VR647 Inhalation System + VR647 Smart Card 2 SecsPhase 1 · CoughClinicalTrials.gov · fetched Nov 12, 2026
- VR647 Inhalation System + VR647 Smart Card 3 SecsPhase 1 · CoughClinicalTrials.gov · fetched Nov 12, 2026
- VR647 Inhalation System + VR647 Smart Card 4 SecsPhase 1 · CoughClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- Study to Compare the Pharmacokinetics and Pharmacodynamics of ASA Powder for Oral Inhalation With Non-enteric-coated Chewable Aspirin in Adult Subjects With Obstructive or Restrictive Pulmonary FunctionPHASE1 · TERMINATED · started Mar 11, 2023ClinicalTrials.gov NCT05625347 · fetched Nov 12, 2026
- Study to Compare the Pharmacodynamics and Pharmacokinetics of Acetylsalicylic Acid Powder for Oral Inhalation With Non-enteric-coated Chewable Aspirin in Healthy Adults.PHASE1 · COMPLETED · started Oct 14, 2022ClinicalTrials.gov NCT05625334 · fetched Nov 12, 2026
- A Study of the Pharmacokinetics, Safety and Tolerability of Single Doses of VR647 Inhalation Suspension Administered Using the VR647 Inhalation System in Children With Wheezing, Reactive Airway Disease or Mild AsthmaPHASE1 · COMPLETED · started Dec 18, 2017ClinicalTrials.gov NCT03421730 · fetched Nov 12, 2026
- A Methodology Trial Using the VR647 Inhalation System in Pediatric Subjects Who Have Previously Received Inhaled TherapyEARLY_PHASE1 · COMPLETED · started Nov 3, 2017ClinicalTrials.gov NCT04011709 · fetched Nov 12, 2026
- A Comparison of VR647 and Conventionally Nebulized Budesonide in Healthy Volunteers and Adult Asthma SubjectsPHASE1 · COMPLETED · started Feb 20, 2017ClinicalTrials.gov NCT04032834 · fetched Nov 12, 2026
- Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of AsthmaPHASE2_PHASE3 · COMPLETED · started Oct 1, 2012ClinicalTrials.gov NCT01720069 · fetched Nov 12, 2026
- Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of AsthmaPHASE2_PHASE3 · COMPLETED · started Oct 1, 2011ClinicalTrials.gov NCT01472757 · fetched Nov 12, 2026